Gamma Knife Dosimetric Differences, TMR 10 Versus Convolution Algorithm
NCT02374983 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2015-03-02
Summary
Gamma Knife Radiosurgery (GKR) is a well established treatment modality for brain tumors and functional disorders of the brain. It relies on mathematical algorithms to predict dose distribution and to calculate the dose at arbitrary points in the head. For the last 25 years, doses applied using Gamma Knife Radiosurgery have been calculated using a simple algorithm, called the Tissue Maximum Ratio algorithm (TMR). Dose planning using this algorithm, relies on a number of approximations to enable fast isodose computation during treatment planning. One of the most significant of these is the approximation of the head to water-equivalent density. The increased electron density of brain and bone (relative to water) and the near-zero density of air cavities in the skull may make significant perturbations to isodose and beam-on time calculations.
With the advent of faster workstations, the effect of tissue in-homogeneities can finally be calculated in reasonable time during the treatment planning process; a newer, more modern algorithm known as convolution algorithm is now commercially available. It uses the values of density indicated in the CT scan to predict the dose distribution and is expected to more accurately calculate radiation dose, although it needs further investigation before clinical implementation. Inter- and intra-indication differences between the old and new algorithms need to be understood before this method can be confidently employed in a clinical setting. It is the aim of this study to understand the dosimetric differences between these dose calculation algorithms and to evaluate the implications of using the convolution algorithm for GKR. A large number of treatments will be re-planned using the convolution algorithm and compared to the TMR plans used to treat the patients. Beam-on-time, which is proportional to dose and a number of commonly used metrics for the targets such as coverage, selectivity, gradient index, and mean and maximum dose, will be estimated with both algorithms. Subgroup analysis will be done to assess whether any factor such as diagnosis, size of the head or location of the target could impact on the relative difference between the methods. The treatment plans will be compared and the potential implications on treatment planning will be elucidated.
Conditions
- Gamma Knife Radiosurgery
Interventions
- OTHER
-
Gamma knife radiosurgery re-planning with convolution algorithm
The convolution algorithm, which uses the correlation between CT imaging density in Hounsfield units (HU) and electron density (ρe) of the tissues as input to predict dose distribution, can provide a better simulation of real delivered dose for GKR. By more accurately predicting the dose delivered, a better prediction of clinical effects can be made, increasing the potential clinical efficacy of treatment. Convolution algorithm is now available in Leksell GammaPlan® 10 but there is not enough clinical data to support its use over TMR 10, which is the current clinical standard. Using convolution algorithm to recalculate the dose for the otherwise unaltered TMR 10 plan will provide valuable insight and understanding of the dosimetric differences between these planning algorithms.
Sponsors & Collaborators
-
University College London Hospitals
collaborator OTHER -
University College, London
lead OTHER
Principal Investigators
-
Neil Kitchen · The National Hospital for Neurology and Neurosurgery
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2015-10-31
- Completion
- 2016-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma
NCT05512195 ·Status: UNKNOWN ·Phase: NA
-
Exploring the Role of 3T MRI in Gamma Knife Radiosurgery
NCT00602992 ·Status: COMPLETED
-
A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)
NCT01821443 ·Status: TERMINATED ·Phase: NA
-
Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)
NCT03294434 ·Status: COMPLETED
-
Radiation Planning Study for High Grade Brain Tumors
NCT01191346 ·Status: COMPLETED
-
Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
NCT02953756 ·Status: COMPLETED
-
A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
NCT06215495 ·Status: RECRUITING ·Phase: NA
-
Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression
NCT04359745 ·Status: UNKNOWN
-
Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification
NCT06296732 ·Status: RECRUITING
-
Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
NCT05735171 ·Status: COMPLETED ·Phase: NA
-
Radiomics for Prediction of Survival in GBM
NCT02666066 ·Status: COMPLETED
-
Image Guided Therapy in the Treatment of Gliomas
NCT01263821 ·Status: TERMINATED ·Phase: NA
-
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
NCT02005614 ·Status: TERMINATED ·Phase: NA
-
Intraoperative Hyperspectral Imaging for Fluorescence Guided Surgery in Low Grade Gliomas
NCT05397574 ·Status: RECRUITING
-
Re-irradiation of High Grade Gliomas: a Quality of Life Study
NCT01711580 ·Status: WITHDRAWN
-
LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
NCT05663125 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI
NCT06201351 ·Status: NOT_YET_RECRUITING
-
Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN
NCT06949436 ·Status: RECRUITING ·Phase: PHASE2
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
NCT04699773 ·Status: RECRUITING ·Phase: NA
-
Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
NCT02329795 ·Status: TERMINATED
-
Navigated Transcranial Magnetic Stimulation in Tumor Surgery
NCT01018290 ·Status: TERMINATED
-
Evaluation of Kidney Function in Children With Brain Tumors
NCT00229801 ·Status: WITHDRAWN ·Phase: NA
-
A Predictive Nomogram for Trismus After Radiotherapy for Head and Neck Cancer
NCT05777668 ·Status: COMPLETED
-
Cavity Boost Radiation Therapy vs. Observation in Cerebral Metastases After Complete Surgical Resection
NCT02887651 ·Status: UNKNOWN ·Phase: NA
-
Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma
NCT06798194 ·Status: NOT_YET_RECRUITING